DXCM vs ISRG
Dexcom (DXCM) and Intuitive Surgical (ISRG) compared side by side. Intuitive Surgical (ISRG) is larger, with a market cap of $159.8B versus $29.4B for Dexcom, about 5.4 times the size. On trailing earnings, DXCM is cheaper at 30.9x versus 54.7x for ISRG.
Head to head
| Metric | DXCM | ISRG |
|---|---|---|
| Market cap | $29.4B | $159.8B |
| P/E (TTM) | 30.9x | 54.7x |
| Forward P/E | 25.0x | 36.4x |
| Revenue (TTM) | $5.0B | $11.6B |
| Revenue growth | 13.1% | 21.7% |
| Gross margin | 62.5% | 66.6% |
| Operating margin | 24.3% | 33.3% |
| Free cash flow | $1.4B | $3.2B |
| Dividend yield | None | None |
| 1-year return | +9.7% | -18.0% |
| 5-year return (annual) | -11.3% | +5.8% |
| Max drawdown | -95% | -82% |
| FI Handbook grade | B+ | B |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
DXCM vs ISRG FAQ
Which is bigger, DXCM or ISRG?
Intuitive Surgical (ISRG) is larger, with a market cap of $159.8B versus $29.4B for Dexcom, about 5.4 times the size.
Is DXCM or ISRG cheaper?
On trailing earnings, DXCM is cheaper at 30.9x versus 54.7x for ISRG. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, DXCM or ISRG?
DXCM returned +9.7% over the past year including dividends, versus -18.0% for ISRG, through October 23, 2026.
Full pages: Dexcom · Intuitive Surgical